Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
High mobility group nucleosome binding domain 1 pseudogene 7 (HMGN1P7) is a processed pseudogene in humans. By definition, a pseudogene is a genomic sequence that resembles a functional gene but is incapable of producing a functional protein product, often due to accumulated detrimental mutations or interruption of key coding domains. HMGN1P7 shares sequence homology with the functional high mobility group nucleosome binding domain 1 (HMGN1) gene but does not encode a functional protein. While some pseudogenes are transcribed into non-coding RNAs and act as regulatory RNAs (e.g., as ceRNAs or miRNA sponges in cancer), there is currently no specific evidence that HMGN1P7 itself plays a direct regulatory or pathological role. It is classified as a "processed pseudogene" and not as a classical drug target.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on High mobility group nucleosome binding domain 1 pseudogene 7 (HMGN1P7).